Skip to main content
logo
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.56
+0.33 (4.56%)
At close: Jun 18, 2026, 4:00 PM EDT
7.60
+0.04 (0.53%)
After-hours: Jun 18, 2026, 5:05 PM EDT

Puma Biotechnology Revenue

Puma Biotechnology had revenue of $44.81M in the quarter ending March 31, 2026, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $227.18M, down -2.38% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%.

Revenue (ttm)
$227.18M
Revenue Growth
-2.38%
P/S Ratio
1.69
Revenue / Employee
$1,269,151
Employees
179
Market Cap
384.80M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025228.37M-2.10M-0.91%
Dec 31, 2024230.47M-5.17M-2.19%
Dec 31, 2023235.64M7.61M3.34%
Dec 31, 2022228.03M-25.12M-9.92%
Dec 31, 2021253.16M28.05M12.46%
Dec 31, 2020225.11M-47.15M-17.32%
Dec 31, 2019272.26M21.27M8.47%
Dec 31, 2018250.99M223.31M806.60%
Dec 31, 201727.69M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Autolus Therapeutics92.62M
REGENXBIO87.82M
Enanta Pharmaceuticals69.21M
X4 Pharmaceuticals9.01M
Adlai Nortye5.00M
Shattuck Labs1.00M
Compass Therapeutics850.00K
Revenue Rankings

PBYI News

More News